New heart valve repair device could help High-Risk patients avoid surgery
NCT ID NCT07243197
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called DragonFly M2 to repair leaky mitral valves in people with moderate-to-severe or severe mitral regurgitation who are at high risk for surgery. The device is inserted through a blood vessel, avoiding open-heart surgery. The study will check if the device is safe and works well in 53 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL VALVE (MV) REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital Chinese Academy of Medical Sciences
Shenzhen, Guangdong, 518000, China
Contact Phone: •••-•••-••••